member
significant_tumor_growth_reduction
cell_cycle
model
model
EgKI-1
EgKI-1
EgKI-1_treatment
model
recombinant_EgKI-1
recombinant_EgKI-1
in_model
EgKI-1
member
member
EgKI-1
EgKI-1_treatment
model
cell_cycle
EgKI-1_treatment
member
model
member
member
co-treatment
cell_growth
cell_growth
cell_cycle
cell_cycle
combined_treatment
investigated
combined_treatment
combined_treatment
treatment
combined_treatment
cells
investigated
cell_proliferation
naringenin
cell_proliferation
investigated
Breast_cancer
investigated
naringenin_treatment_group
treatment
investigated
combined_treatment
naringenin
cell_proliferation
co-treatment
treatment
naringenin
treatment
cell_migration
naringenin
treatment
cell_proliferation
combined_treatment
purpose
3D_phantom
random_distribution
modality
breast_lesion_model
tumor_models
characteristics
3D_phantom
uniform_distribution
random_distribution
time-enhancement_curves
3D_static_phantom
perfusion
tumor_models
3D_phantom
distribution
tumor_models
modality
typical_4D_phantom
distribution
uniform_random_distribution
uniform_random_distribution
proposed_digital_phantom
typical_4D
modality
modality
3D_static_phantom
arterial_sources
detection_diagnosis
distribution
uniform_distribution
Results
proposed_digital_phantom
random_distribution
distribution
curves
distribution
modality
modality
corresponding_curves
proposed_phantom
uniform_distribution
corresponding_time-enhancement_curves
modality
phantom
random_distribution
exponential
modality
tumor_models
digital_phantom
modality
curves
activities
percent_cytotoxicity
aqueous_Orthosiphon_pallidus_extract
objective
Orthosiphon_pallidus_extract
percent_cytotoxicity
Orthosiphon_pallidus_extract
activities
anticancer_activities
anticancer_activities
percent_cytotoxicity
Orthosiphon_pallidus_extract
percent_cytotoxicity
Orthosiphon_pallidus_extract
percent_cytotoxicity
objective
percent_cytotoxicity
objective
activities
total
potent_activity
objective
percent_cytotoxicity
Orthosiphon_pallidus_extract
percent_cytotoxicity
percent_cytotoxicity
Orthosiphon_pallidus_extract
retrospective_study
retrospective_study
196_patients
serious_damage
retrospective_study
retrospective_study
patients
anthracycline-based_adjuvant_therapies
serious_damage
study
women
damage
damage
clinicians
patients
patients
Most_patients
clinicians
analysis
Patient_self-reports
Most_patients
Female_patients
patients
T-PAT_participants
effects
patients
findings
compound
findings
repeated_preparations
compound
compound
Targeting_breast_CSCs
repeated_preparations
aldehyde_dehydrogenase
chromatographic_preparations
compound
repeated_chromatographic_preparations
Targeting_breast_CSCs
findings
chromatographic_preparations
preparations
preparations
repeated_chromatographic_preparations
compound
Targeting_breast_CSCs
Patients
G1
G1
patients
Hypofractionated_VMAT-SIB
outcomes
cosmetic_outcomes
VMAT-SIB
outcomes
cosmetic_outcomes
patients
Cosmetic_outcomes
outcomes
Our_data
G1
outcomes
Cosmetic_outcomes
Hypofractionated_VMAT-SIB
patients
Hypofractionated_VMAT-SIB
outcomes
Patients
Hypofractionated_VMAT-SIB
Patients
patients
patients
cosmetic_outcomes
patients
assays
Higher_expression
clinicopathological_parameters
patients
clinicopathological_parameters
effect
Enhanced_understanding
Higher_expression
several_parameters
several_clinicopathological_parameters
Higher_expression
assays
late_recurrences
intervention
several_parameters
several_clinicopathological_parameters
expression
expression
expression
late_recurrence_risk
recurrence_selection_tools
showing
late_recurrence_selection_tools
parameters
effect
parameters
intervention
predicting
Long-term_intervention
Extended_endocrine_therapy
recurrence_selection_tools
multigene_assays
intervention
Enhanced_understanding
showing
showing
Higher_expression
intervention
diagnosis
Long-term_intervention
Extended_endocrine_therapy
Extended_therapy
Long-term_intervention
late_recurrence_selection_tools
Enrichment_Analysis
understanding
Higher_expression
expression
late_recurrences
Long-term_intervention
Long-term_intervention
intervention
intervention
expression
Long-term_intervention
Long-term_intervention
recurrence_selection_tools
expression
Higher_expression
therapy
estrogen_receptor
Extended_therapy
patients
multigene_assays
showing
therapy
late_recurrence_selection_tools
Ongoing_research
important_growth_pathway
data
therapies
mTOR_inhibitor_everolimus
Analysis
Analysis
mTOR_inhibitor_everolimus
Ongoing_research
Ongoing_research
majority
therapies
research
research
anti-estrogen_therapy
data
majority
therapy
patients
agents
management_challenges
therapies
PI3K/AKT/mTOR_pathway
selective_estrogen_receptor_modulators
therapies
therapies
mTOR_inhibitor_everolimus
Ongoing_research
data
supportive_care
mTOR_inhibitor_everolimus
mTOR_inhibitor_everolimus
therapy
data
therapies
patients
therapies
mTOR_inhibitor_everolimus
therapy
PI3K/AKT/mTOR_pathway
therapy
deaths
research
therapies
mTOR_inhibitor_everolimus
research
therapies
treatment
Sexual_function
problems
participants
Sexual_function
dysfunctions
main_problems
participants
average_time
primary_sexual_dysfunctions
instruments
study
main_problems
changes
circumstances
514_women
main_problems
study
events
ERÎ±_polyubiquitination_selective_estrogen_receptor_degraders
regulator
transcriptional_regulator
transcriptional_regulator
posttranslational_modifications_interactions
related
extranuclear_activity
may_key_factor
regulator
activity
polyubiquitination
related
transcriptional_regulator
related
ERÎ±_polyubiquitination_estrogen_receptor_degraders
polyubiquitination
increase
transcriptional_regulator
regulator
related
regulator
ERÎ±_polyubiquitination_estrogen_receptor_degraders
regulator
ERÎ±_polyubiquitination
transcriptional_regulator
extranuclear_activity
ERÎ±_polyubiquitination_selective_estrogen_receptor_degraders
transcriptional_regulator
specific_protein_complexes
aim
Its_potential_practical_applications
aim
patients
Its_potential_practical_applications
patients
One_photograph
patients
Its_potential_applications
Its_potential_practical_applications
One_photograph
Their_treatment-related_cosmetic_changes
patients
patients
Its_potential_applications
patients
One_photograph
patients
changes
Its_potential_applications
Agreement
patients
One_photograph
correlation_coefficient
intraclass_correlation_coefficient
Its_potential_practical_applications
patients
partial_breast_irradiation
accelerated_partial_breast_irradiation
further_investigation
S961
IR_antagonist_S961
effect
IR_mRNA_expression_levels
expression
expression
study
S961
study
study
IR_mRNA_expression_levels
S961
study
study
study
breast_cancer_cells
mRNA_expression
upregulated_expression
breast_cancer_cells
S961
study
IR_mRNA_expression_levels
aspects
expression
study
several_aspects
several_aspects
S961
breast_cancer_cells
expression
breast_cancer_cells
mRNA_expression
IR_mRNA_expression_levels
expression
proliferation
aspects
breast_cancer_cells
IR_mRNA_expression_levels
IR_antagonist_S961
S961
S961
expression
study
upregulated_expression
breast_cancer_cells
expression
study
IR_mRNA_expression_levels
S961
expression
IR_signalling
IR_mRNA_expression_levels
breast_cancer_cells
Immediate_Verbal_Memory_Index
breast_radiotherapy
mechanisms
association
mechanisms
changes
changes
Memory_decline
mechanisms
adjuvant_breast_radiotherapy
The_Delayed
The_Delayed
breast_radiotherapy
Immediate_Verbal_Memory_Index
three_visual_representations
TAMs/CXCL1
epithelial-mesenchymal_transition
CXCL1_silencing
therapeutic_targets
significant_reduction
therapeutic_targets
QPCR_screening
QPCR_screening
QPCR_screening
targets
targets
CXCL1_silencing
QPCR_screening
therapeutic_targets
high_CXCL1_expression
TAMs/CXCL1
QPCR_screening
targets
QPCR_screening
therapeutic_targets
QPCR_screening
targets
targets
CXCL1_silencing
targets
targets
CXCL1
therapeutic_targets
targets
CXCL1
therapeutic_targets
QPCR_screening
high_CXCL1_expression
therapeutic_targets
targets
CXCL1_silencing
targets
CXCL1_expression
QPCR_screening
CXCL1_expression
therapeutic_targets
3_patients
4_patients
Level_1_group
patients
other_patients
doses
efficacy
patients
dose
doses
ERI
combination_therapy
dose
Japanese_patients
tolerability
I_clinical_study
patients
type
Breast_cancer
